REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 7th, 2021 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations • Nevada
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 3, 2021, by and between Oncotelic Therapeutics, Inc., a Delaware corporation (the “Company”), and PEAK ONE OPPORTUNITY FUND, L.P., a Delaware limited partnership (together with it permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the equity purchase agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • May 7th, 2021 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations • Nevada
This equity purchase agreement is entered into as of May 3, 2021 (this “Agreement”), by and between Oncotelic Therapeutics, Inc., a Delaware corporation (the “Company”), and Peak One Opportunity Fund, L.P., a Delaware limited partnership (the “Investor”).
